Pathstone Holdings »

Axsome Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $290k 3.6k 79.59

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Axsome Therapeutics

Vanguard Group
Fairmount Funds Management
BVF
Citadel Advisors
Perceptive Advisors
RA Capital Management
Millennium Management
Point72 Asset Management
Alethea Capital Management
Bellevue Group
Partner Fund Management
Avidity Partners Management
Boxer Capital
Eventide Asset Management
Tang Capital Management

View all funds holding Axsome Therapeutics